Detalhe da pesquisa
1.
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.
Blood
; 139(2): 177-187, 2022 01 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34758069
2.
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Eur Respir J
; 61(2)2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36180086
3.
Conversion of Problematic Winery Waste into Valuable Substrate for Baker's Yeast Production and Solid Biofuel: A Circular Economy Approach§.
Food Technol Biotechnol
; 61(4): 430-438, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38205048
4.
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
Int J Cancer
; 146(5): 1307-1315, 2020 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31498894
5.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30514803
6.
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial.
Am J Hematol
; 99(6): 1192-1195, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38578022
7.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Breast Cancer Res Treat
; 161(1): 63-72, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27798749
8.
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.
Ann Hematol
; 96(9): 1463-1470, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28725989
9.
Adverse reactions in mRCC patients documented in routine practice by German office-based oncologists and uro-oncologists.
J Oncol Pharm Pract
; 23(4): 288-295, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26908232
10.
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.
Int J Cancer
; 139(1): 177-86, 2016 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26891420
11.
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Ann Hematol
; 93(7): 1167-76, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24658964
12.
ABC7 Consensus: Assessment by a German Group of Experts.
Breast Care (Basel)
; 19(2): 116-128, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38638343
13.
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212).
Clin Cancer Res
; 30(7): 1256-1263, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38289994
14.
Adjuvant treatment with S-1 in patients after R0-resection of adenocarcinoma of the stomach and esophagogastric junction - A multicenter phase I/II feasibility study (GMBH-STO-0114).
Oncol Res Treat
; 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38565089
15.
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
Lancet Oncol
; 13(6): 579-88, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22503032
16.
Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil.
Cancer Med
; 12(3): 2580-2589, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35941837
17.
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Eur J Cancer
; 190: 112955, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37454537
18.
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).
J Clin Oncol
; 41(16): 2975-2987, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37018649
19.
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass).
Eur Urol
; 84(6): 571-578, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37758574
20.
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS.
J Pharm Biomed Anal
; 221: 115033, 2022 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36148722